After years of restructuring, Chicago-based Exicure has South Korean majority ownership and is buying the U.S. arm of a South Korean oncology biotech firm.
With all the discussion about the potential of GenAI, what is the biggest technology challenge facing consumer and retail companies? Our clients have been kicking the tires on generative AI for ...